Stay updated on Aducanumab in Early Alzheimer's Clinical Trial

Sign up to get notified when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Aducanumab in Early Alzheimer's Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A sitewide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T21:57:51.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2 while the page continued to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T22:28:43.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:41:03.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record details. This indicates access restrictions on the page rather than content updates.
    Difference
    17%
    Check dated 2026-09-20T22:32:52.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page adds a 2015 U.S. NIH Grant/Contract funding line and updates the page revision to v3.6.6, removing the previous v3.6.5 reference.
    Difference
    0.0%
    Check dated 2026-08-30T22:24:33.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5, indicating a minor backend/system update with no user-facing content changes.
    Difference
    0.0%
    Check dated 2026-08-09T11:03:47.000Z thumbnail image

Stay in the know with updates to Aducanumab in Early Alzheimer's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.